CHOLESTECH CORPORATION Contracts & Agreements

52 Contracts & Agreements

Browse by Contract Category

Contracts

FORM OF CHOLESTECH CORPORATION AMENDMENT TO SEVERANCE AGREEMENT (Filed With SEC on August 2, 2007)
FORM OF CHOLESTECH CORPORATION AMENDMENT TO CHANGE OF CONTROLSEVERANCE AGREEMENT (Filed With SEC on August 2, 2007)
AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG INVERNESS MEDICAL INNOVATIONS, INC., IRIS MERGER SUB, INC. AND CHOLESTECH CORPORATION (Filed With SEC on June 4, 2007)
Current assets (Filed With SEC on February 1, 2006)
Current assets (Filed With SEC on February 1, 2006)
Exhibit No (Filed With SEC on December 12, 2005)
Exhibit No (Filed With SEC on December 12, 2005)
Current assets (Filed With SEC on August 3, 2005)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $244 billion (Filed With SEC on June 8, 2005)
Entry into a Material Definitive Agreement (Filed With SEC on February 2, 2005)
Entry into a Material Definitive Agreement (Filed With SEC on February 2, 2005)
Exhibit No (Filed With SEC on January 5, 2005)
Lease Agreement Addendum No. One by and between Cholestech and BIV Group dated November 19, 2004 (Filed With SEC on November 23, 2004)
Current assets (Filed With SEC on November 3, 2004)
Current assets (Filed With SEC on November 3, 2004)
CHOLESTECH CORPORATION SEVERANCE AGREEMENT (Filed With SEC on October 14, 2004)
CHOLESTECH CORPORATION CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 14, 2004)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion (Filed With SEC on June 8, 2004)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion (Filed With SEC on June 8, 2004)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion (Filed With SEC on June 8, 2004)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion (Filed With SEC on June 8, 2004)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion (Filed With SEC on June 8, 2004)
In 2002, the estimated cost in the United States of coronary heart disease and diabetes was $245 billion (Filed With SEC on June 8, 2004)
FINANCIAL INFORMATION (Filed With SEC on February 5, 2004)
FINANCIAL INFORMATION (Filed With SEC on February 5, 2004)
FINANCIAL INFORMATION (Filed With SEC on February 5, 2004)
FINANCIAL INFORMATION (Filed With SEC on February 5, 2004)
FINANCIAL INFORMATION (Filed With SEC on February 5, 2004)
FINANCIAL INFORMATION (Filed With SEC on February 5, 2004)
FINANCIAL INFORMATION (Filed With SEC on November 6, 2003)
FINANCIAL INFORMATION (Filed With SEC on August 7, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 25, 2003)
Legal Proceedings (Filed With SEC on June 18, 2002)
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Filed With SEC on November 8, 2001)
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Filed With SEC on November 8, 2001)
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Filed With SEC on November 8, 2001)